Detection of androst-4-ene-3,6,17-trione (6-OXO) and its metabolites in urine by gas chromatography-mass spectrometry in relation to doping analysis.
暂无分享,去创建一个
[1] W. Van Thuyne,et al. Validation of a GC-MS screening method for anabolizing agents in solid nutritional supplements. , 2004, Biomedical chromatography : BMC.
[2] P. Van Eenoo,et al. The Prevalence of Doping in Flanders in Comparison to the Prevalence of Doping in International Sports , 2003, International journal of sports medicine.
[3] P. Eenoo,et al. Prohormones and sport , 2002, The Journal of Steroid Biochemistry and Molecular Biology.
[4] N. Chauret,et al. Evaluation of human hepatocyte incubation as a new tool for metabolism study of androstenedione and norandrostenedione in a doping control perspective. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[5] D. Kerkhof. Steroid profiling in doping analysis , 2001 .
[6] M Saugy,et al. Test methods: anabolics. , 2000, Bailliere's best practice & research. Clinical endocrinology & metabolism.
[7] C. Ayotte,et al. Testing for natural and synthetic anabolic agents in human urine. , 1996, Journal of chromatography. B, Biomedical applications.
[8] M. Numazawa,et al. Mechanism for aromatase inactivation by a suicide substrate, androst-4-ene-3,6,17-trione. The 4 beta, 5 beta-epoxy-19-oxo derivative as a reactive electrophile irreversibly binding to the active site. , 1996, Biochemical pharmacology.
[9] S. Horning,et al. Metabolism of anabolic steroids in humans: Synthesis of 6β-hydroxy metabolites of 4-chloro-1,2-dehydro-17α-methyltestosterone, fluoxymesterone, and metandienone , 1995, Steroids.
[10] M. Donike,et al. Metabolism of anabolic steroids in man: synthesis and use of reference substances for identification of anabolic steroid metabolites , 1993 .
[11] M. Numazawa,et al. Studies on aromatase inhibition with 4-androstene-3,6,17-trione: its 3 beta-reduction and time-dependent irreversible binding to aromatase with human placental microsomes. , 1987, Journal of steroid biochemistry.
[12] D. Covey,et al. Enzyme-generated intermediates derived from 4-androstene-3,6,17-trione and 1,4,6-androstatriene-3,17-dione cause a time-dependent decrease in human placental aromatase activity. , 1981, Endocrinology.
[13] M. Briggs,et al. Steroid biochemistry and pharmacology , 1970 .